The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Takayasu's arteritis 3
SANDOSTATIN LAR DEPOT Thinking abnormal 3
SANDOSTATIN LAR DEPOT Thyroid cancer 3
SANDOSTATIN LAR DEPOT Thyroid function test abnormal 3
SANDOSTATIN LAR DEPOT Tibia fracture 3
SANDOSTATIN LAR DEPOT Tongue biting 3
SANDOSTATIN LAR DEPOT Tongue discolouration 3
SANDOSTATIN LAR DEPOT Trigger finger 3
SANDOSTATIN LAR DEPOT Tumour haemorrhage 3
SANDOSTATIN LAR DEPOT Urine analysis abnormal 3
SANDOSTATIN LAR DEPOT Uterine cyst 3
SANDOSTATIN LAR DEPOT Uterine leiomyoma 3
SANDOSTATIN LAR DEPOT Venous pressure increased 3
SANDOSTATIN LAR DEPOT Vital functions abnormal 3
SANDOSTATIN LAR DEPOT Vitamin D decreased 3
SANDOSTATIN LAR DEPOT Weight fluctuation 3
SANDOSTATIN LAR DEPOT Wound complication 3
SANDOSTATINE LAR Fall 3
SANDOSTATIN 5-hydroxyindolacetic acid in urine increased 2
SANDOSTATIN Abdominal lymphadenopathy 2

Total Records: 2,045     Number of Pages: 103